1AI 11.1% 0.8¢ algorae pharmaceuticals limited

what can we expect next, page-4

  1. 1,039 Posts.
    lightbulb Created with Sketch. 16
    Three years of trials seem to make the stock a long term investment. Dont buy it for a quick gain. But, having said that, the 25mln dlr investment from a japanese pharma might be a precursor for a friendly take-over
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.